Role of ML in Cancer Prediction
Lecture Notes in Networks and Systems, ISSN: 2367-3389, Vol: 1053 LNNS, Page: 211-226
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Conference Paper Description
Cancer continues to be a major worldwide health concern, necessitating precise and timely forecasting for efficient detection and treatment. As useful tools in this field, machine-learning (ML) approaches use cutting-edge algorithms to analyze complex datasets and discover insightful patterns. The purpose of this study is to investigate how machine learning (ML) can be utilized for forecasting cancer and the way this may affect patient outcomes. To train ML models, crucial features such as DNA sequencing, gene expression profiles, demographic data, medical history, diagnostic tests, and treatment outcomes are combined. In order to enable personalized care strategies based on particular biomarkers and patient-specific information, prognostic models are created to evaluate the likelihood of illness recurrence and patient survival. Additionally, ML approaches enhance clinical decision-making processes by discovering prospective drug targets, improving treatment regimens, and offering predictive insights. Further study is required, nevertheless, due to issues like promising model correctness and reliability, resolving data imbalance, and taking ethical considerations into account. In order to increase early detection, better treatment options, and eventually effectively defeat cancer, this research emphasizes the great potential of machine learning (ML) in cancer forecasting.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85207832520&origin=inward; http://dx.doi.org/10.1007/978-981-97-4860-0_18; https://link.springer.com/10.1007/978-981-97-4860-0_18; https://dx.doi.org/10.1007/978-981-97-4860-0_18; https://link.springer.com/chapter/10.1007/978-981-97-4860-0_18
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know